SLC22A17 and cancer: On the other hand, the intracellular iron overload induced by SLC22A17 downregulation could have detrimental effects on cancer cell survival increasing oxidative stress and activating ferroptosis during pharmacological treatment (Lin et al., 2020; Wu et al., 2020).